Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with Type 2 Diabetes

Details for Australian Patent Application No. 2004206829 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Gerstein, Hertzel; Rosskamp, Ralf

Agent Watermark

Pub. Number AU-B-2004206829

PCT Pub. Number WO2004/064862

Priority 60/439,941 14.01.03 US

Filing date 14 January 2004

Wipo publication date 5 August 2004

Acceptance publication date 8 April 2010

International Classifications

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 July 2005 PCT application entered the National Phase

  PCT publication WO2004/064862 Priority application(s): WO2004/064862

8 April 2010 Application Accepted

  Published as AU-B-2004206829

5 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206835-Composition and method for preventing or treating a virus infection

2004206827-Compositions and methods for combination antiviral therapy